Project Number 1R21AG069183-01 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Evolving CRISPR-based platforms for the discovery of Alzheimer relevant neurodegenerative pathways Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 17. Genetics i. Functional Validation of Genetic Risk and Protective Factors Researcher and Organization Principal Investigator MUCKE, LENNART Principal Investigator First Name LENNART Principal Investigator Last Name MUCKE Awardee Organization J. DAVID GLADSTONE INSTITUTES Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-19-071: Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed) FY Overall Cost $519,750 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official WISE, BRADLEY C
